32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.51.Z - Wholesale trade
62.01.Z - Activities related to programming, IT consulting, and related activities
62.02.Z - Activities related to programming, IT consulting, and related activities
62.03 - Activities related to programming, IT consulting, and related activities
63.11 - Services related to computing infrastructure, data processing, website management (hosting), and other information services
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
72.19 - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -16,6 | -10,2 | -10,4 | -2,2 |
EBITDA | -16,1 | -9,9 | -10,3 | -3,7 |
Short time liabilities | 2 | 4 | 4,3 | 8,1 |
Equity capital | 1,7 | 30,8 | 54,6 | 77,6 |
Operating profit (EBIT) | -16,6 | -10,2 | -10,4 | -2,2 |
Assets | 7,7 | 42,3 | 69,6 | 64,4 |
Net profit (loss) | -16,6 | -10,2 | -10,4 | -2,2 |
Cash | 2,1 | 5,3 | 9,9 | 86,2 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 5,9 | 11,6 | 14,9 | 29,1 |
Working assets | 2,9 | 6,1 | 11 | 79,2 |
Depreciation | 0,5 | 0,3 | 0,1 | -53,3 |
% | % | % | p.p. | |
Profitability of capital | -963,8 | -33,1 | -19,1 | 14 |
Equity capital to total assets | 22,5 | 72,7 | 78,5 | 5,8 |
Gross profit margin | ||||
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.4897482991218567 | 0.5306361317634583 | 0.7598472833633423 | 0,3 |
Net dept to EBITDA | 0.13033036887645721 | 0.5347843170166016 | 0.9598503708839417 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane